RDNT RadNet, Inc.

69.51USD-3.22%Mkt Cap: 5.48B USDP/E: —

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its servic…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap5.48B USD
Enterprise Value7.40B USD
Revenue (TTM)2.38B USD
Gross Profit235.49M USD
Net Income (TTM)-18.65M USD
Revenue/Share30.82 USD
Last Price69.51 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees12.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)66.20
PEG0.96
EV/EBITDA25.50
EV/Revenue3.10
P/S2.30
P/B4.88
EPS (TTM)-0.29 USD
EPS (Forward)1.05 USD
52W Range
50.8253% of range85.84
52W High85.84 USD
52W Low50.82 USD
Profitability
Gross Margin11.54%
Oper. Margin4.69%
EBITDA Margin12.17%
Profit Margin-0.91%
ROE-1.71%
ROA-0.50%
ROIC1.82%
ROCE2.63%
Growth
Revenue Growth22.10%
Earnings Growth-28.60%
Cash Flow & Leverage
Operating CF298.82M USD
CapEx (TTM)213.25M USD
FCF Margin6.93%
FCF Yield3.02%
Net Debt1.42B USD
Net Debt/EBITDA4.91
Net Debt/FCF8.61
Balance Sheet
Debt/Equity1.71
Current Ratio1.49
Quick Ratio1.40
Book Value/Sh14.23 USD
Cash/Share9.53 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2
Split DateNov 28, 2006
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)97.00 USD
Upside (mean)+39.5%
Target Range83.00 USD – 108.00 USD
83.00+39.5% to mean108.00
# Analysts8
Ownership
Shares Out.78.77M
Float65.88M
Insiders9.89%
Institutions104.80%
Short Interest
Short Ratio16.9d
Short % Float13.33%
Short % Out.11.27%
Shares Short8.88M
Short (prev mo.)9.36M
Technical
SMA 5072.84 (-4.6%)
SMA 20065.41 (+6.3%)
Beta1.40
S&P 52W Chg12.08%
Avg Vol (30d)675.68K
Avg Vol (10d)953.29K
Technical Indicators
RSI (14)38.8
MACD0.4598
MACD Signal1.1958
MACD Hist.-0.7360
BB Upper80.82 USD
BB Middle74.76 USD
BB Lower68.70 USD
BB Width16.22%
ATR (14)2.971 USD
Vol Ratio (20d)0.95x

About RadNet (NASDAQ: RDNT)

›

RadNet (NASDAQ: RDNT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 12,000 employees.

The shares were at 69.51 USD on 19 November 2026, down 11.0% over 52 weeks. Its 52-week range is 50.82 USD to 85.84 USD: the price is 19.0% below the high and 36.8% above the low.

Its market capitalisation is 5.48B USD.

RadNet reports return on equity of -1.7%, an operating margin of 4.7% and revenue up 22.1% year over year.

Its debt exceeds its cash by 1.42B USD, a debt-to-equity ratio of 1.71. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 8 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 97.00 USD is 39.5% above the current price. The next earnings report is expected on 25 February 2027.